Site US10051 — Loma Linda, California

Site US10051 is a clinical research site located in Loma Linda, California, United States 92350.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Site US10051 has participated in 1 clinical trials.

Therapeutic areas: Non-small Cell Lung Cancer (NSCLC).

Sponsors: Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Loma Linda

Browse all research sites in California · View every site in Loma Linda

• Loma Linda University Faculty Medical Offices
• Implant Department, School of dentistry, Loma Linda University
• Loma Linda University, Department of Nutrition
• Site 70 - Loma Linda University, Department of Pediatrics, 11175 Campus Street; CP A1120
• Loma Linda University Emergency Department
• Loma Linda University Surgical Hospital
• Loma Linda University Children Hospital
• Loma Linda University Eye Institute
• Loma Linda University Health
• Loma Linda University Center for Health Promotion
• Loma Linda University Pediatric Clinics
• Loma Linda University Medical Center-Transplantation Institu

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10051?

Site US10051 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10051 conducted?

Site US10051 has 1 clinical trials on record. Their work covers Non-small Cell Lung Cancer (NSCLC).

Is Site US10051 accredited by Crixeo Clinical Trials?

Site US10051 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10051?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.